These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 2881449

  • 1. Transmitter receptor alterations in Parkinson's disease.
    Calne DB, Stoessl AJ.
    Adv Neurol; 1987; 45():45-9. PubMed ID: 2881449
    [No Abstract] [Full Text] [Related]

  • 2. Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
    Kito S, Miyoshi R, Mizuno K, Nitta K, Matsubayashi H, Yamamura Y, Tahara E.
    Adv Neurol; 1987; 45():159-65. PubMed ID: 2881441
    [No Abstract] [Full Text] [Related]

  • 3. Neurotransmitter receptor mapping by autoradiography and other methods.
    Kuhar MJ, De Souza EB, Unnerstall JR.
    Annu Rev Neurosci; 1986; 9():27-59. PubMed ID: 2423006
    [No Abstract] [Full Text] [Related]

  • 4. [Problems and future perspectives in the treatment of Parkinson's disease].
    Hens L, Hellemans J.
    Tijdschr Gerontol Geriatr; 1982 Aug; 13(4):147-54. PubMed ID: 6127822
    [Abstract] [Full Text] [Related]

  • 5. Neurotransmitter receptor alterations in Parkinson's disease.
    Reisine TD, Fields JZ, Yamamura HI.
    Life Sci; 1977 Aug 01; 21(3):335-43. PubMed ID: 197361
    [No Abstract] [Full Text] [Related]

  • 6. Brain neurotransmitters and neuropeptides in Parkinson's disease.
    Rinne UK, Rinne JO, Rinne JK, Laakso K, Lönnberg P.
    Acta Physiol Pharmacol Latinoam; 1984 Aug 01; 34(3):287-99. PubMed ID: 6099688
    [Abstract] [Full Text] [Related]

  • 7. Nondopaminergic neurons in Parkinson's disease.
    Hirsch EC, Orieux G, Muriel MP, Francois C, Feger J.
    Adv Neurol; 2003 Aug 01; 91():29-37. PubMed ID: 12449099
    [No Abstract] [Full Text] [Related]

  • 8. Drug-induced alterations in neurotransmitter receptor binding and function.
    Enna SJ, Ferkany JW, Strong R.
    Adv Biochem Psychopharmacol; 1980 Aug 01; 21():253-63. PubMed ID: 6246740
    [No Abstract] [Full Text] [Related]

  • 9. Biochemical pathophysiology of Parkinson's disease.
    Hornykiewicz O, Kish SJ.
    Adv Neurol; 1987 Aug 01; 45():19-34. PubMed ID: 2881444
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A Markov process based model of the neurotransmitter-receptor binding process in the brain.
    Elkarmi AZ, Karmi MZ, Alkarmi ZM.
    Drug Des Deliv; 1988 Jul 01; 3(1):69-76. PubMed ID: 2908226
    [Abstract] [Full Text] [Related]

  • 12. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B.
    Biol Psychiatry; 1984 Mar 01; 19(3):361-83. PubMed ID: 6144329
    [Abstract] [Full Text] [Related]

  • 13. [Regulatory effects of the presynaptic receptors on transmitter release (author's transl)].
    Yang K.
    Sheng Li Ke Xue Jin Zhan; 1982 Jan 01; 13(1):43-7. PubMed ID: 6125032
    [No Abstract] [Full Text] [Related]

  • 14. Absolute quantification by positron emission tomography of the endogenous ligand.
    Delforge J, Bottlaender M, Pappata S, Loc'h C, Syrota A.
    J Cereb Blood Flow Metab; 2001 May 01; 21(5):613-30. PubMed ID: 11333372
    [Abstract] [Full Text] [Related]

  • 15. Brain enkephalin receptors in Parkinson's disease.
    Rinne UK, Rinne JK, Rinne JO, Laakso K, Tenovuo O, Lönnberg P, Koskinen V.
    J Neural Transm Suppl; 1983 May 01; 19():163-71. PubMed ID: 6321647
    [Abstract] [Full Text] [Related]

  • 16. Positron emission tomography studies of brain receptors.
    Mazière B, Mazière M.
    Fundam Clin Pharmacol; 1991 May 01; 5(1):61-91. PubMed ID: 1676695
    [Abstract] [Full Text] [Related]

  • 17. Environmental enrichment and neurotransmitter receptors.
    Por SB, Bennett EL, Bondy SC.
    Behav Neural Biol; 1982 Feb 01; 34(2):132-40. PubMed ID: 6123308
    [No Abstract] [Full Text] [Related]

  • 18. Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal modulation.
    Uhl GR, Hackney GO, Torchia M, Stranov V, Tourtellotte WW, Whitehouse PJ, Tran V, Strittmatter S.
    Ann Neurol; 1986 Aug 01; 20(2):194-203. PubMed ID: 3019228
    [Abstract] [Full Text] [Related]

  • 19. Positron emission tomography for quantitative in vivo studies of neurotransmitter kinetics: a critical evaluation.
    Greitz T.
    Adv Biochem Psychopharmacol; 1984 Aug 01; 39():69-78. PubMed ID: 6147069
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic use of release-modifying drugs.
    Langer SZ.
    Handb Exp Pharmacol; 2008 Aug 01; (184):561-73. PubMed ID: 18064425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.